Acta Neurologica Scandinavica

Gamma-hydroxybutyrate - a drug of abuse
pp. 145-156(12)
Authors: Drasbek, K. R.; Christensen, J.; Jensen, K.

Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?
pp. 157-168(12)
Authors: Zaccara, G.; Messori, A.; Cincotta, M.; Burchini, G.

Levetiracetam: a long-term follow-up study of efficacy and safety
pp. 169-176(8)
Authors: Bauer, J.; Ben-Menachem, E.; Krämer, G.; Fryze, W.; Da Silva, S.; Kasteleijn-Nolst Trenité, D. G. A.

A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy
pp. 177-180(4)
Authors: Grosskopf, J.; Mazzola, J.; Wan, Y.; Hopwood, M.

Patient satisfaction with switching to Stalevo: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study)
pp. 181-186(6)
Authors: Myllylä, V.; Haapaniemi, T.; Kaakkola, S.; Kinnunen, E.; Hartikainen, P.; Nuutinen, J.; Rissanen, A.; Kuopio, A. M.; Jolma, T.; Satomaa, O.; Heikkinen, H.

Determinants of early outcome in spontaneous lobar cerebral hemorrhage
pp. 187-192(6)
Authors: Arboix, A.; Manzano, C.; García-Eroles, L.; Massons, J.; Oliveres, M.; Parra, O.; Targa, C.

Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension
pp. 193-197(5)
Authors: Bicakci, K.; Bicakci, S.; Aksungur, E.

Health-related quality of life in narcolepsy
pp. 198-204(7)
Authors: Ervik, S.; Abdelnoor, M.; Heier, M.S.; Ramberg, M.; Strand, G.

Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis
pp. 205-209(5)
Authors: Iłżecka, J.

Clinical characterization and evaluation of DYT1 gene in Indian primary dystonia patients
pp. 210-215(6)
Authors: Naiya, T.; Biswas, A.; Neogi, R.; Datta, S.; Misra, A. K.; Das, S. K.; Ray, K.; Ray, J.